Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DIALysis With EXpanded Solute Removal

NCT: NCT06660277 · RECRUITING

NCT IDNCT06660277
StatusRECRUITING
Start Date2025-08-12
Completion2031-04
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to evaluate the health effects of expanded hemodialysis in patients receiving hemodialysis. The main question it aims to answer is: 1\) Does expanded hemodialysis reduce the risk of death from any cause? Researchers will compare expanded hemodialysis to conventional hemodialysis (the treatment currently used for the majority of patients receiving hemodialysis) to see if expanded hemodialysis works to improve patient outcomes. Participants will continue to receive their regularly scheduled hemodialysis treatments using either a super high-flux/expanded dialysis filter or a high-flux/conventional dialysis filter. All other aspects of treatments remain the same. No additional tests or visits are required. Data will be obtained using administrative healthcare databases and medical record review (at a subset of participating locations).

Frequently Asked Questions

What is DIALysis With EXpanded Solute Removal?

DIALysis With EXpanded Solute Removal is a clinical trial registered under NCT06660277. Current status: RECRUITING.

What is the status of NCT06660277?

The current status of NCT06660277 (DIALysis With EXpanded Solute Removal) is: RECRUITING.

When did DIALysis With EXpanded Solute Removal start?

DIALysis With EXpanded Solute Removal started on 2025-08-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑